From: Semi-allogeneic vaccines and tumor-induced immune tolerance
GENE | FUNCTION | Fold UP-Regulation (DOWN-Regulation) |
---|---|---|
BTLA | Induced during activation of T cells; Expressed on Th1 cells; Interacts with B7 homolog B7H4. | 3.0; 2.7 |
CD40 | Co-stimulatory molecule expressed by B cells, dendritic cells, and follicular dendritic cells. | 2.6; 2.7 |
CD40L | Expressed by activated T cells; Binds to CD40 on APC. | 1.6, 2.1 |
CD70 | Expressed by activated T and B cells; Induces proliferation of co-stimulated T cells; Enhances the generation of CTLs. | 3.0, 1.7 |
FASLG | Interacts with FAS and triggers apoptosis. | 2.1, 2.2 |
GZMB | Granzyme B is crucial for apoptosis of target Cells by CTLs. | 3.2, 2.4 |
HDAC9 | Histone deacetylase 9, transcriptional repressor. | 3.4, 2.7 |
ICOS | Inducible T-cell co-stimulator. | 2.2, 1.7 |
IFNG | Th1- and dendritic cell-specific cytokine. | 5.5 |
LTA | Lymphotoxin α or tumor necrosis factor β. | 2.1, 1.7 |
PRF1 | Perforin, key CTL effector molecule. | 2.4, 2.6 |
TBX21 | Th1-specific transcription factor that controls the expression of IFN-γ. | 2.6 |
TNFRSF4 | Receptor involved in CD4+ T cell response. | 2.0, 2.1 |
TNFSF10 | TNF-like cytokine; Induces apoptosis of tumor cells. | 2.1, 1.6 |
TNFSF8 | TNF-like cytokine; Induces apoptosis of some lymphoma cells. | 2.1, 1.7 |
CCR4 | Receptor for CC chemokines. | (2.9, 2.0) |
GATA3 | Transcription factor that favors expression of Th2-type cytokines. | (2.4, 1.5) |
IL5 | Cytokine for growth and differentiation of B cells and eosinophils. | (1.3, 4.1) |
IL6 | Inhibits T cell activation; Inhibits the CD40L system; Induces a Th2-type cytokine response. | (5.9, 6.7) |
LAT | Required for TCR-mediated signaling; Possibly associated with overstimulation and apoptosis of T cells. | (2.8, 2.1) |
PDCD1 | Induction and maintenance of T-cell tolerance. | (2.7, 2.0) |
RNF128 | Involved in induction of anergic phenotype | (5.4, 4.5) |
TNFRSF8 | Positive regulator of apoptosis; Limits proliferation of CD+ effector T cells. | (4.7, 2.8) |